Performance & Formulation Insights for AccessCARE Scar
How AccessCARE Scar Works
AccessCARE Scar is a clinically tested, phyto-derived active combining Allium cepa (Onion) Extract, Centella asiatica Leaf Extract, and Broussonetia papyrifera (Paper Mulberry) Bark Extract. This targeted botanical blend delivers dual-action benefits: skin brightening through tyrosinase inhibition and visible scar erythema reduction. Key bioactives including asiaticoside, quercetin, and Kazinol F work synergistically to support the skin’s natural recovery process, reduce post-inflammatory redness, and promote a more even, uniform complexion in scar-affected areas. In a 28-day clinical study on 20 women aged 25–45 with recent scars, a 4% cream applied twice daily demonstrated visible improvements in scar appearance.
Formulation Guidelines
AccessCARE Scar is a water-soluble liquid (in Butylene Glycol) designed for incorporation into the water phase of targeted scar treatments, recovery serums, post-procedure creams, and brightening formulations. The recommended use level is 4%. Add during the cool-down stage at temperatures below 40°C (104°F) to maintain the bioactivity of the quercetin and asiaticoside compounds. It is compatible within a cosmetic pH range of 4.5–6.5 and pairs well with skin-recovery actives such as allantoin, panthenol, centella-derived ingredients, and niacinamide. Avoid combining with strong oxidizing agents that may degrade the polyphenol actives.
Key Formulation Benefits
- Scar Erythema Reduction: Clinically demonstrated to visibly reduce post-inflammatory redness in scar tissue over 28 days.
- Skin Brightening: Kazinol F and quercetin support tyrosinase inhibition for a more even complexion in scar-affected areas.
- Skin Recovery Support: Asiaticoside from Centella asiatica promotes skin repair and supports the natural healing process.
- Naturally Derived & Vegan: 100% plant-sourced actives suitable for clean beauty and vegan formulations.
- Targeted Treatment: Designed for scar-specific applications at a 4% use level for optimal clinical results.
